PepGen

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PepGen and other ETFs, options, and stocks.

About PEPG

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.

CEO

James Gregg McArthur

CEOJames Gregg McArthur

Employees

Employees81

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2018

Founded2018

Employees

Employees81

PEPG Key Statistics

Market cap

49.86M

Market cap49.86M

Price-Earnings ratio

-0.54

Price-Earnings ratio-0.54

Dividend yield

—

Dividend yield—

Average volume

217.53K

Average volume217.53K

High today

$1.68

High today$1.68

Low today

$1.52

Low today$1.52

Open price

$1.68

Open price$1.68

Volume

151.51K

Volume151.51K

52 Week high

$19.30

52 Week high$19.30

52 Week low

$0.8801

52 Week low$0.8801

PepGen

Why Robinhood?

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. Show more

PEPG Key Statistics

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases.